search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Infection Control & Hospital Epidemiology


957


P<.0001), the number of days from declaring an outbreak to starting oseltamivir (t=3.48; df=51; P=.001), the prevalence of ILI among residents at the start of the outbreak (t=2.04; df=51; P=.047), the number of residents at risk at the start of the outbreak (t=4.02; df=51; P=.0002), and the staff vacci- nation rate at the start of the outbreak (t=2.09; df=25; P=.047). Using a stepwise forward modeling strategy, where initial


criteria for being included in the model was having a P value<.15 and removal from the model with a P value>.20, only 3 variables were found to be statistically significant (Table 2): the number of days from the second case to starting oseltamivir (t=6.04; df= 49; P<.0001), the number of days from the first case to the second case (t=3.35; df=49; P=.002), and the number of resi- dents at risk at the start of the outbreak (t=4.22; df=49; P=.0001). The inclusion of the prevalence of ILI in the model did not


Fig. 1. Outbreaks included and excluded from analysis.


Table 1. Summary of Influenza A H3N2 Outbreak Characteristics Characteristic


No. of cases (n=53)


Total no. of residents (n=53) Secondary cases (n=53)a


Residents excluding primary cases (n=53)a Secondary case attack rate (%) (n=53)a


No. days from 2nd case to chemoprophylaxis (n=53) No. days between 1st and 2nd cases (n=53)


No. days between 2nd case and declaring outbreak (n=53) Prevalence of ILI among residents (n=53), %b,c Prevalence of ILI among staff (n=26), %b,c Staff vaccinated (n=27), %c Residents vaccinated (n=40), %c Hygiene score (n=27)d Rural (Y/N) (n=53)e Private6 (Y/N) (n=53)f


change the odds ratios (ORs) of the 3 statistically significant independent variables. In addition, no other control variables significantly affected the model because the timing of oseltamivir chemoprophylaxis remained statistically significant (P values ranging from .002 to <.0001) in all other 4 variable models with an OR ranging from 1.27 to 1.37 in these models. Therefore, the final main effects model includes the 3 statistically significant variables. The main effects model was assessed for collinearity. The variance inflation factor was well below 10, so there was no


Average 14.57 99.21 10.38 95.02 14.24 3.85 1.17 2.08 6.29 0.55


34.07 82.73 74.29 0.51 0.30


Minimum Value 3


16 0


13 0 0 0 0


0.9 0 8 3


49 0 0


Maximum Value 81


431 77


427 67 11 6


10 19


6.6 96


100 100 1 1


Standard Deviation 13.41 76.72 12.23 76.46 13.73 2.52 1.65 2.20 5.03 1.42


22.16 16.71 14.23 0.50 0.46


NOTE. n, number of facilities with available information; ILI, influenza-like illness. aPrimary cases are defined as cases of ILI occurring on or before the day that the second case occurred; and Secondary cases are defined as all cases of ILI occurring after the primary cases. bILI is characterized as acute onset of respiratory illness with fever and cough and with 1 or more of the following: sore throat, arthralgia, myalgia, or prostration that could be due to


influenza.9 cAt the start of the outbreak. dHand hygiene score in the facility during the 2014–2015 influenza season. If >1 audit occurred during this time, scores were averaged. eRural=a population less than 10,000 in the 2011 Health Canada Census (1=yes, 0=no). fFacilities not directly operated by the Regional Health Authority (1=yes, 0=no).


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128  |  Page 129  |  Page 130  |  Page 131  |  Page 132  |  Page 133  |  Page 134  |  Page 135  |  Page 136  |  Page 137  |  Page 138  |  Page 139  |  Page 140